Global and Japan Subcutaneous Biologics Market Size, Status and Forecast 2024-2031

Report ID: 1024335 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.6 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Subcutaneous Biologics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Syringe
        1.2.3 Wearable injector
        1.2.4 Automatic injector
        1.2.5 Implants
    1.3 Market by Application
        1.3.1 Global Subcutaneous Biologics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital pharmacies
        1.3.3 Retail pharmacies
        1.3.4 Drug stores
        1.3.5 Online pharmacies
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Subcutaneous Biologics Market Perspective (2016-2027)
    2.2 Subcutaneous Biologics Growth Trends by Regions
        2.2.1 Subcutaneous Biologics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Subcutaneous Biologics Historic Market Share by Regions (2016-2021)
        2.2.3 Subcutaneous Biologics Forecasted Market Size by Regions (2022-2027)
    2.3 Subcutaneous Biologics Industry Dynamic
        2.3.1 Subcutaneous Biologics Market Trends
        2.3.2 Subcutaneous Biologics Market Drivers
        2.3.3 Subcutaneous Biologics Market Challenges
        2.3.4 Subcutaneous Biologics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Subcutaneous Biologics Players by Revenue
        3.1.1 Global Top Subcutaneous Biologics Players by Revenue (2016-2021)
        3.1.2 Global Subcutaneous Biologics Revenue Market Share by Players (2016-2021)
    3.2 Global Subcutaneous Biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Subcutaneous Biologics Revenue
    3.4 Global Subcutaneous Biologics Market Concentration Ratio
        3.4.1 Global Subcutaneous Biologics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Subcutaneous Biologics Revenue in 2020
    3.5 Subcutaneous Biologics Key Players Head office and Area Served
    3.6 Key Players Subcutaneous Biologics Product Solution and Service
    3.7 Date of Enter into Subcutaneous Biologics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Subcutaneous Biologics Breakdown Data by Type
    4.1 Global Subcutaneous Biologics Historic Market Size by Type (2016-2021)
    4.2 Global Subcutaneous Biologics Forecasted Market Size by Type (2022-2027)

5 Subcutaneous Biologics Breakdown Data by Application
    5.1 Global Subcutaneous Biologics Historic Market Size by Application (2016-2021)
    5.2 Global Subcutaneous Biologics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Subcutaneous Biologics Market Size (2016-2027)
    6.2 North America Subcutaneous Biologics Market Size by Type
        6.2.1 North America Subcutaneous Biologics Market Size by Type (2016-2021)
        6.2.2 North America Subcutaneous Biologics Market Size by Type (2022-2027)
        6.2.3 North America Subcutaneous Biologics Market Size by Type (2016-2027)
    6.3 North America Subcutaneous Biologics Market Size by Application
        6.3.1 North America Subcutaneous Biologics Market Size by Application (2016-2021)
        6.3.2 North America Subcutaneous Biologics Market Size by Application (2022-2027)
        6.3.3 North America Subcutaneous Biologics Market Size by Application (2016-2027)
    6.4 North America Subcutaneous Biologics Market Size by Country
        6.4.1 North America Subcutaneous Biologics Market Size by Country (2016-2021)
        6.4.2 North America Subcutaneous Biologics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Subcutaneous Biologics Market Size (2016-2027)
    7.2 Europe Subcutaneous Biologics Market Size by Type
        7.2.1 Europe Subcutaneous Biologics Market Size by Type (2016-2021)
        7.2.2 Europe Subcutaneous Biologics Market Size by Type (2022-2027)
        7.2.3 Europe Subcutaneous Biologics Market Size by Type (2016-2027)
    7.3 Europe Subcutaneous Biologics Market Size by Application
        7.3.1 Europe Subcutaneous Biologics Market Size by Application (2016-2021)
        7.3.2 Europe Subcutaneous Biologics Market Size by Application (2022-2027)
        7.3.3 Europe Subcutaneous Biologics Market Size by Application (2016-2027)
    7.4 Europe Subcutaneous Biologics Market Size by Country
        7.4.1 Europe Subcutaneous Biologics Market Size by Country (2016-2021)
        7.4.2 Europe Subcutaneous Biologics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Subcutaneous Biologics Market Size (2016-2027)
    8.2 Asia-Pacific Subcutaneous Biologics Market Size by Type
        8.2.1 Asia-Pacific Subcutaneous Biologics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Subcutaneous Biologics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Subcutaneous Biologics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Subcutaneous Biologics Market Size by Application
        8.3.1 Asia-Pacific Subcutaneous Biologics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Subcutaneous Biologics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Subcutaneous Biologics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Subcutaneous Biologics Market Size by Region
        8.4.1 Asia-Pacific Subcutaneous Biologics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Subcutaneous Biologics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Subcutaneous Biologics Market Size (2016-2027)
    9.2 Latin America Subcutaneous Biologics Market Size by Type
        9.2.1 Latin America Subcutaneous Biologics Market Size by Type (2016-2021)
        9.2.2 Latin America Subcutaneous Biologics Market Size by Type (2022-2027)
        9.2.3 Latin America Subcutaneous Biologics Market Size by Type (2016-2027)
    9.3 Latin America Subcutaneous Biologics Market Size by Application
        9.3.1 Latin America Subcutaneous Biologics Market Size by Application (2016-2021)
        9.3.2 Latin America Subcutaneous Biologics Market Size by Application (2022-2027)
        9.3.3 Latin America Subcutaneous Biologics Market Size by Application (2016-2027)
    9.4 Latin America Subcutaneous Biologics Market Size by Country
        9.4.1 Latin America Subcutaneous Biologics Market Size by Country (2016-2021)
        9.4.2 Latin America Subcutaneous Biologics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Subcutaneous Biologics Market Size (2016-2027)
    10.2 Middle East & Africa Subcutaneous Biologics Market Size by Type
        10.2.1 Middle East & Africa Subcutaneous Biologics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Subcutaneous Biologics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Subcutaneous Biologics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Subcutaneous Biologics Market Size by Application
        10.3.1 Middle East & Africa Subcutaneous Biologics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Subcutaneous Biologics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Subcutaneous Biologics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Subcutaneous Biologics Market Size by Country
        10.4.1 Middle East & Africa Subcutaneous Biologics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Subcutaneous Biologics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Abbott Laboratories
        11.1.1 Abbott Laboratories Company Details
        11.1.2 Abbott Laboratories Business Overview
        11.1.3 Abbott Laboratories Subcutaneous Biologics Introduction
        11.1.4 Abbott Laboratories Revenue in Subcutaneous Biologics Business (2016-2021)
        11.1.5 Abbott Laboratories Recent Development
    11.2 Pfizer Inc.
        11.2.1 Pfizer Inc. Company Details
        11.2.2 Pfizer Inc. Business Overview
        11.2.3 Pfizer Inc. Subcutaneous Biologics Introduction
        11.2.4 Pfizer Inc. Revenue in Subcutaneous Biologics Business (2016-2021)
        11.2.5 Pfizer Inc. Recent Development
    11.3 Genentech Inc.
        11.3.1 Genentech Inc. Company Details
        11.3.2 Genentech Inc. Business Overview
        11.3.3 Genentech Inc. Subcutaneous Biologics Introduction
        11.3.4 Genentech Inc. Revenue in Subcutaneous Biologics Business (2016-2021)
        11.3.5 Genentech Inc. Recent Development
    11.4 Novartis AG
        11.4.1 Novartis AG Company Details
        11.4.2 Novartis AG Business Overview
        11.4.3 Novartis AG Subcutaneous Biologics Introduction
        11.4.4 Novartis AG Revenue in Subcutaneous Biologics Business (2016-2021)
        11.4.5 Novartis AG Recent Development
    11.5 Biogen Idec
        11.5.1 Biogen Idec Company Details
        11.5.2 Biogen Idec Business Overview
        11.5.3 Biogen Idec Subcutaneous Biologics Introduction
        11.5.4 Biogen Idec Revenue in Subcutaneous Biologics Business (2016-2021)
        11.5.5 Biogen Idec Recent Development
    11.6 AbbVie Inc.
        11.6.1 AbbVie Inc. Company Details
        11.6.2 AbbVie Inc. Business Overview
        11.6.3 AbbVie Inc. Subcutaneous Biologics Introduction
        11.6.4 AbbVie Inc. Revenue in Subcutaneous Biologics Business (2016-2021)
        11.6.5 AbbVie Inc. Recent Development
    11.7 F. Hoffmann-La Roche AG
        11.7.1 F. Hoffmann-La Roche AG Company Details
        11.7.2 F. Hoffmann-La Roche AG Business Overview
        11.7.3 F. Hoffmann-La Roche AG Subcutaneous Biologics Introduction
        11.7.4 F. Hoffmann-La Roche AG Revenue in Subcutaneous Biologics Business (2016-2021)
        11.7.5 F. Hoffmann-La Roche AG Recent Development
    11.8 Bristol-Myers Squibb
        11.8.1 Bristol-Myers Squibb Company Details
        11.8.2 Bristol-Myers Squibb Business Overview
        11.8.3 Bristol-Myers Squibb Subcutaneous Biologics Introduction
        11.8.4 Bristol-Myers Squibb Revenue in Subcutaneous Biologics Business (2016-2021)
        11.8.5 Bristol-Myers Squibb Recent Development
    11.9 Eisai Inc.
        11.9.1 Eisai Inc. Company Details
        11.9.2 Eisai Inc. Business Overview
        11.9.3 Eisai Inc. Subcutaneous Biologics Introduction
        11.9.4 Eisai Inc. Revenue in Subcutaneous Biologics Business (2016-2021)
        11.9.5 Eisai Inc. Recent Development
    11.10 Takeda Pharmaceuticals Ltd.
        11.10.1 Takeda Pharmaceuticals Ltd. Company Details
        11.10.2 Takeda Pharmaceuticals Ltd. Business Overview
        11.10.3 Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Introduction
        11.10.4 Takeda Pharmaceuticals Ltd. Revenue in Subcutaneous Biologics Business (2016-2021)
        11.10.5 Takeda Pharmaceuticals Ltd. Recent Development
    11.11 Alnylam Pharmaceuticals
        11.11.1 Alnylam Pharmaceuticals Company Details
        11.11.2 Alnylam Pharmaceuticals Business Overview
        11.11.3 Alnylam Pharmaceuticals Subcutaneous Biologics Introduction
        11.11.4 Alnylam Pharmaceuticals Revenue in Subcutaneous Biologics Business (2016-2021)
        11.11.5 Alnylam Pharmaceuticals Recent Development
    11.12 Bayer AG
        11.12.1 Bayer AG Company Details
        11.12.2 Bayer AG Business Overview
        11.12.3 Bayer AG Subcutaneous Biologics Introduction
        11.12.4 Bayer AG Revenue in Subcutaneous Biologics Business (2016-2021)
        11.12.5 Bayer AG Recent Development
    11.13 GlaxoSmithKline
        11.13.1 GlaxoSmithKline Company Details
        11.13.2 GlaxoSmithKline Business Overview
        11.13.3 GlaxoSmithKline Subcutaneous Biologics Introduction
        11.13.4 GlaxoSmithKline Revenue in Subcutaneous Biologics Business (2016-2021)
        11.13.5 GlaxoSmithKline Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Subcutaneous Biologics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Syringe
    Table 3. Key Players of Wearable injector
    Table 4. Key Players of Automatic injector
    Table 5. Key Players of Implants
    Table 6. Global Subcutaneous Biologics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Subcutaneous Biologics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Subcutaneous Biologics Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Subcutaneous Biologics Market Share by Regions (2016-2021)
    Table 10. Global Subcutaneous Biologics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Subcutaneous Biologics Market Share by Regions (2022-2027)
    Table 12. Subcutaneous Biologics Market Trends
    Table 13. Subcutaneous Biologics Market Drivers
    Table 14. Subcutaneous Biologics Market Challenges
    Table 15. Subcutaneous Biologics Market Restraints
    Table 16. Global Subcutaneous Biologics Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Subcutaneous Biologics Market Share by Players (2016-2021)
    Table 18. Global Top Subcutaneous Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Biologics as of 2020)
    Table 19. Ranking of Global Top Subcutaneous Biologics Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Subcutaneous Biologics Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Subcutaneous Biologics Product Solution and Service
    Table 23. Date of Enter into Subcutaneous Biologics Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Subcutaneous Biologics Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Subcutaneous Biologics Revenue Market Share by Type (2016-2021)
    Table 27. Global Subcutaneous Biologics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Subcutaneous Biologics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Subcutaneous Biologics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Subcutaneous Biologics Revenue Market Share by Application (2016-2021)
    Table 31. Global Subcutaneous Biologics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Subcutaneous Biologics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Subcutaneous Biologics Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Subcutaneous Biologics Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Subcutaneous Biologics Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Subcutaneous Biologics Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Subcutaneous Biologics Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Subcutaneous Biologics Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Subcutaneous Biologics Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Subcutaneous Biologics Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Subcutaneous Biologics Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Subcutaneous Biologics Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Subcutaneous Biologics Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Subcutaneous Biologics Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Subcutaneous Biologics Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Subcutaneous Biologics Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Subcutaneous Biologics Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Subcutaneous Biologics Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Subcutaneous Biologics Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Subcutaneous Biologics Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Subcutaneous Biologics Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Subcutaneous Biologics Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Subcutaneous Biologics Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Subcutaneous Biologics Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Subcutaneous Biologics Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Subcutaneous Biologics Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Subcutaneous Biologics Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Subcutaneous Biologics Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Subcutaneous Biologics Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Subcutaneous Biologics Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Subcutaneous Biologics Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Subcutaneous Biologics Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Abbott Laboratories Company Details
    Table 64. Abbott Laboratories Business Overview
    Table 65. Abbott Laboratories Subcutaneous Biologics Product
    Table 66. Abbott Laboratories Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
    Table 67. Abbott Laboratories Recent Development
    Table 68. Pfizer Inc. Company Details
    Table 69. Pfizer Inc. Business Overview
    Table 70. Pfizer Inc. Subcutaneous Biologics Product
    Table 71. Pfizer Inc. Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
    Table 72. Pfizer Inc. Recent Development
    Table 73. Genentech Inc. Company Details
    Table 74. Genentech Inc. Business Overview
    Table 75. Genentech Inc. Subcutaneous Biologics Product
    Table 76. Genentech Inc. Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
    Table 77. Genentech Inc. Recent Development
    Table 78. Novartis AG Company Details
    Table 79. Novartis AG Business Overview
    Table 80. Novartis AG Subcutaneous Biologics Product
    Table 81. Novartis AG Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
    Table 82. Novartis AG Recent Development
    Table 83. Biogen Idec Company Details
    Table 84. Biogen Idec Business Overview
    Table 85. Biogen Idec Subcutaneous Biologics Product
    Table 86. Biogen Idec Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
    Table 87. Biogen Idec Recent Development
    Table 88. AbbVie Inc. Company Details
    Table 89. AbbVie Inc. Business Overview
    Table 90. AbbVie Inc. Subcutaneous Biologics Product
    Table 91. AbbVie Inc. Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
    Table 92. AbbVie Inc. Recent Development
    Table 93. F. Hoffmann-La Roche AG Company Details
    Table 94. F. Hoffmann-La Roche AG Business Overview
    Table 95. F. Hoffmann-La Roche AG Subcutaneous Biologics Product
    Table 96. F. Hoffmann-La Roche AG Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
    Table 97. F. Hoffmann-La Roche AG Recent Development
    Table 98. Bristol-Myers Squibb Company Details
    Table 99. Bristol-Myers Squibb Business Overview
    Table 100. Bristol-Myers Squibb Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
    Table 101. Bristol-Myers Squibb Recent Development
    Table 102. Eisai Inc. Company Details
    Table 103. Eisai Inc. Business Overview
    Table 104. Eisai Inc. Subcutaneous Biologics Product
    Table 105. Eisai Inc. Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
    Table 106. Eisai Inc. Recent Development
    Table 107. Takeda Pharmaceuticals Ltd. Company Details
    Table 108. Takeda Pharmaceuticals Ltd. Business Overview
    Table 109. Takeda Pharmaceuticals Ltd. Subcutaneous Biologics Product
    Table 110. Takeda Pharmaceuticals Ltd. Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
    Table 111. Takeda Pharmaceuticals Ltd. Recent Development
    Table 112. Alnylam Pharmaceuticals Company Details
    Table 113. Alnylam Pharmaceuticals Business Overview
    Table 114. Alnylam Pharmaceuticals Subcutaneous Biologics Product
    Table 115. Alnylam Pharmaceuticals Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
    Table 116. Alnylam Pharmaceuticals Recent Development
    Table 117. Bayer AG Company Details
    Table 118. Bayer AG Business Overview
    Table 119. Bayer AG Subcutaneous Biologics Product
    Table 120. Bayer AG Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
    Table 121. Bayer AG Recent Development
    Table 122. GlaxoSmithKline Company Details
    Table 123. GlaxoSmithKline Business Overview
    Table 124. GlaxoSmithKline Subcutaneous Biologics Product
    Table 125. GlaxoSmithKline Revenue in Subcutaneous Biologics Business (2016-2021) & (US$ Million)
    Table 126. GlaxoSmithKline Recent Development
    Table 127. Research Programs/Design for This Report
    Table 128. Key Data Information from Secondary Sources
    Table 129. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Subcutaneous Biologics Market Share by Type: 2020 VS 2027
    Figure 2. Syringe Features
    Figure 3. Wearable injector Features
    Figure 4. Automatic injector Features
    Figure 5. Implants Features
    Figure 6. Global Subcutaneous Biologics Market Share by Application: 2020 VS 2027
    Figure 7. Hospital pharmacies Case Studies
    Figure 8. Retail pharmacies Case Studies
    Figure 9. Drug stores Case Studies
    Figure 10. Online pharmacies Case Studies
    Figure 11. Subcutaneous Biologics Report Years Considered
    Figure 12. Global Subcutaneous Biologics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Subcutaneous Biologics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Subcutaneous Biologics Market Share by Regions: 2020 VS 2027
    Figure 15. Global Subcutaneous Biologics Market Share by Regions (2022-2027)
    Figure 16. Global Subcutaneous Biologics Market Share by Players in 2020
    Figure 17. Global Top Subcutaneous Biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Subcutaneous Biologics as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Subcutaneous Biologics Revenue in 2020
    Figure 19. Global Subcutaneous Biologics Revenue Market Share by Type (2016-2021)
    Figure 20. Global Subcutaneous Biologics Revenue Market Share by Type (2022-2027)
    Figure 21. North America Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Subcutaneous Biologics Market Share by Type (2016-2027)
    Figure 23. North America Subcutaneous Biologics Market Share by Application (2016-2027)
    Figure 24. North America Subcutaneous Biologics Market Share by Country (2016-2027)
    Figure 25. United States Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Subcutaneous Biologics Market Share by Type (2016-2027)
    Figure 29. Europe Subcutaneous Biologics Market Share by Application (2016-2027)
    Figure 30. Europe Subcutaneous Biologics Market Share by Country (2016-2027)
    Figure 31. Germany Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Subcutaneous Biologics Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Subcutaneous Biologics Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Subcutaneous Biologics Market Share by Region (2016-2027)
    Figure 41. China Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Subcutaneous Biologics Market Share by Type (2016-2027)
    Figure 49. Latin America Subcutaneous Biologics Market Share by Application (2016-2027)
    Figure 50. Latin America Subcutaneous Biologics Market Share by Country (2016-2027)
    Figure 51. Mexico Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Subcutaneous Biologics Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Subcutaneous Biologics Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Subcutaneous Biologics Market Share by Country (2016-2027)
    Figure 57. Turkey Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Subcutaneous Biologics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Abbott Laboratories Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
    Figure 61. Pfizer Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
    Figure 62. Genentech Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
    Figure 63. Novartis AG Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
    Figure 64. Biogen Idec Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
    Figure 65. AbbVie Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
    Figure 66. F. Hoffmann-La Roche AG Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
    Figure 67. Bristol-Myers Squibb Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
    Figure 68. Eisai Inc. Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
    Figure 69. Takeda Pharmaceuticals Ltd. Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
    Figure 70. Alnylam Pharmaceuticals Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
    Figure 71. Bayer AG Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
    Figure 72. GlaxoSmithKline Revenue Growth Rate in Subcutaneous Biologics Business (2016-2021)
    Figure 73. Bottom-up and Top-down Approaches for This Report
    Figure 74. Data Triangulation
    Figure 75. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Laboratories
Pfizer Inc.
Genentech Inc.
Novartis AG
Biogen Idec
AbbVie Inc.
F. Hoffmann-La Roche AG
Bristol-Myers Squibb
Eisai Inc.
Takeda Pharmaceuticals Ltd.
Alnylam Pharmaceuticals
Bayer AG
GlaxoSmithKline
Frequently Asked Questions
Subcutaneous Biologics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Subcutaneous Biologics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Subcutaneous Biologics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Forged Ring

Forged Ring market is segmented by region (country), players, by Type, and by Application. Player ... Read More

Cryogenic Rack

Cryogenic Rack market is segmented by region (country), players, by Type, and by Application. Pla ... Read More

Slammed Pipette

Slammed Pipette market is segmented by region (country), players, by Type, and by Application. Pl ... Read More